This is a video podcast by Gwen Owen, former pharmaceutical representative, who left the industry in 2000, and now exposes the pharmaceutical industry’s agenda of Deceive, Drug Maintenance (for life) and Symptoms Management. In this broadcast, she addresses specifically their approach with anti-depressants and anti-psychotic drugs which are designed to make patients customers for life, and do indeed make it almost impossible for patients to withdraw, titrate and stop using the drugs.
Gwen Olsen spent 15 years as a sales rep in the pharmaceutical industry working for health care giants. When her niece committed suicide after being put on a changing regimen of anti-depressants and antipsychotics, and from her own experience of anti-depressants, she began re-evaluating the drugs she was promoting and pushing.
The FDA has stated that the adverse effects reported on Medwatch are actually 1 to 10 times that of those reported. Suicidal ideation was not listed as a risk factor on the drug information sheet for Seroquel in 2013 and 2014. After my son’s suicide in 2014, I sent a Medwatch report from 2008 showing statistics for suicide attempts and suicides while on Seroquel and its generic form to the psychiatrist who prescribed it. In 2015, risk of suicide ideation and suicide was put on the drug label. This is how the drug industry works to protect its interests only.
When a psychiatrist tells you that your loved one with schizophrenia must be on anti-psychotic drugs for life, they are representing what they have been told by the drug industry whose only agenda is medicine maintenance – profit maintenance.